Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
207.40    0.40 (0.19%)
Bid:
207.40
Ask:
207.60
Spread: 0.20 (0.096%)
Market Cap: £4.05b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Board Committee Changes

30 Jun 2020 07:00

RNS Number : 4447R
ConvaTec Group PLC
30 June 2020
 

 

 

Board Committee Changes

 

Reading, United Kingdom (30 June 2020) 

 

The Board of ConvaTec Group Plc ("ConvaTec" or "the Company") confirms that in light of recent changes to the Directors that it has reconstituted the Committees of the Board as set out below. All changes shall take effect on 1 September 2020.

 

Remuneration Committee

Brian May shall serve as Chair along with Regina Benjamin who is an existing member, and Rick Anderson shall be appointed as a new member. Margaret Ewing shall step down from the Committee.

 

Audit and Risk Committee

Margaret Ewing shall continue to serve as Chair along with Brian May who is an existing member, and Heather Mason shall be appointed as a new member.

 

Nomination Committee

John McAdam shall continue to serve as Chair along with Margaret Ewing and Rick Anderson who are existing members, and Regina Benjamin, Heather Mason and Brian May shall be appointed as new members.

 

This announcement is made in accordance with Listing Rule 9.6.11R(3).

 

Enquiries:

Analysts and Investors

Mark Reynolds, Director Investor Relations +44 (0)7551 036 625

ir@convatec.com

 

Media

Buchanan: Charles Ryland/Chris Lane/Vicky Hayns +44 (0)207 466 5000

 

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has established market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUKVWRRSUNUAR
Date   Source Headline
18th Sep 20197:00 amRNSAcquisition
12th Sep 20194:00 pmRNSScrip Dividend - Calculation Price
19th Aug 20197:00 amRNSJohn McAdam appointed Chairman of ConvaTec
8th Aug 20194:30 pmRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSConvaTec Group Plc First Half Results 2019
25th Jun 20197:00 amRNSBOARD CHANGE
20th Jun 20192:20 pmRNSDirector Declaration
31st May 20193:30 pmRNSTotal Voting Rights
17th May 201912:30 pmRNSDirector/PDMR Shareholding
9th May 20194:30 pmRNSResult of AGM
3rd May 20197:00 amRNSConvaTec Q1 Trading Update
29th Apr 20192:30 pmRNSScrip Dividend - total issued shares
18th Apr 20192:47 pmRNSHolding(s) in Company
11th Apr 20192:15 pmRNSScrip Dividend - calculation price
11th Apr 201910:00 amRNSHolding(s) in Company
10th Apr 201910:30 amRNSHolding(s) in Company
3rd Apr 20198:45 amRNSNotice of AGM
29th Mar 201911:52 amRNSDirector/PDMR Shareholding
29th Mar 201911:21 amRNSHolding(s) in Company
25th Mar 20197:01 amRNSBoard changes
25th Mar 20197:00 amRNSAppointment of Chief Executive Officer
6th Mar 20191:00 pmRNSDirector/PDMR Shareholding
27th Feb 201912:40 pmRNS2018 Annual Report & Accounts
14th Feb 20197:04 amRNSFourth Quarter and Annual Results 2018
8th Jan 20192:00 pmRNSHolding(s) in Company
2nd Jan 201910:30 amRNSHolding(s) in Company
18th Dec 20182:15 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20186:42 pmRNSDirector/PDMR Shareholding
22nd Oct 20182:00 pmRNSHolding(s) in Company
19th Oct 201811:30 amRNSHolding(s) in Company
16th Oct 20185:15 pmRNSDirector/PDMR Shareholding
16th Oct 20181:15 pmRNSDirector/PDMR Shareholding
16th Oct 201810:15 amRNSDirector/PDMR Shareholding
15th Oct 20182:30 pmRNSDirector/PDMR Shareholding
15th Oct 20187:00 amRNSRetirement of Chief Executive Officer
15th Oct 20187:00 amRNS3rd Quarter Results
28th Sep 201811:30 amRNSScrip Dividend - total issued shares
13th Sep 20184:00 pmRNSScrip Dividend - calculation price
13th Sep 201810:10 amRNSHolding(s) in Company
13th Sep 201810:00 amRNSHolding(s) in Company
7th Aug 20189:23 amRNSHolding(s) in Company
6th Aug 20182:36 pmRNSDirector/PDMR Shareholding
3rd Aug 201811:55 amRNSDirector/PDMR Shareholding
3rd Aug 201811:25 amRNSDirector/PDMR Shareholding
2nd Aug 20187:00 amRNSConvaTec Group Plc First Half Results 2018
27th Jul 201812:35 pmRNSHolding(s) in Company
24th Jul 20187:00 amRNSUS FDA 510(k) Clearance for AQUACELT Ag Advantage
23rd Jul 20183:27 pmRNSHolding(s) in Company
23rd Jul 20189:39 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.